Evolocumab superior to ezetimibe in lowering LDL cholesterol
Evolocumab, an injected form of a class of drugs called PCSK9 inhibitors that lower low-density lipoprotein cholesterol, also known as LDL-C or "bad cholesterol," outperformed ezetimibe with few side effects in patients unable ...
Mar 31, 2014
0
0